Size | Price | Stock | Qty |
---|---|---|---|
500mg |
|
||
1g |
|
||
2g |
|
||
5g |
|
||
10g |
|
||
Other Sizes |
|
Purity: ≥98%
Phenoxybenzamine HCl (formerly NSC-37448; NSC37448; Dibenzyline, NCI-C01661, NCIC01661; NCI-c01661), the hydrochloride salt of Phenoxybenzamine, is a potent, non-specific, irreversible alpha-adrenergic receptor antagonist with antihypertensive effects. Its IC50 of 550 nM indicates that it inhibits the alpha-adrenergic receptor. In particular, hypertension brought on by pheochromocytoma has been treated with phenoxybenzamine. When it comes to other a-blockers, its action starts later and lasts longer. Even though it is rarely used now, it was the first alpha blocker to be used for the treatment of benign prostatic hyperplasia.
Targets |
α-adrenoceptor
|
||
---|---|---|---|
ln Vitro |
|
||
ln Vivo |
|
||
Cell Assay |
Following cytometry, 1x3 cells are seeded in a 96-well plate with 100 μL of DMEM that has been enhanced with 10% FBS. WST-1 (Water Soluble Tetrazolium) is added to cells in ten microliters (10% of the total volume) and incubated for 30 min at 37°C before the colorimetric assay with 450 nm excitation and 630 nm emission at 24 h intervals up to 96 h. The standard curve is used to calculate the cell number after the mean fluorescence value has been counted.
|
||
Animal Protocol |
|
||
References |
|
Molecular Formula |
C18H23CL2NO
|
|
---|---|---|
Molecular Weight |
340.3
|
|
Exact Mass |
339.12
|
|
Elemental Analysis |
C, 63.53; H, 6.81; Cl, 20.84; N, 4.12; O, 4.70
|
|
CAS # |
63-92-3
|
|
Related CAS # |
Phenoxybenzamine; 59-96-1; Phenoxybenzamine-d5 hydrochloride; 1329838-45-0; Phenoxybenzamine (benzyl-2,3,4,5,6-d5) (hydrochloride); 1398065-71-8
|
|
Appearance |
White to off-white crystalline powder
|
|
SMILES |
CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2.Cl
|
|
InChi Key |
VBCPVIWPDJVHAN-UHFFFAOYSA-N
|
|
InChi Code |
InChI=1S/C18H22ClNO.ClH/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17;/h2-11,16H,12-15H2,1H3;1H
|
|
Chemical Name |
N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine;hydrochloride
|
|
Synonyms |
|
|
HS Tariff Code |
2934.99.9001
|
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
|
---|
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.9386 mL | 14.6929 mL | 29.3858 mL | |
5 mM | 0.5877 mL | 2.9386 mL | 5.8772 mL | |
10 mM | 0.2939 mL | 1.4693 mL | 2.9386 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
NCT Number | Recruitment | interventions | Conditions | Sponsor/Collaborators | Start Date | Phases |
NCT05702944 | Recruiting | Drug: Phenoxybenzamine | Pheochromocytoma Paraganglioma |
Seoul National University Hospital |
January 18, 2023 | Phase 4 |
NCT01379898 | Completed | Drug: Phenoxybenzamine Drug: Doxazosin |
Pheochromocytoma | University Medical Center Groningen |
December 2011 | Phase 4 |
NCT00569855 | Completed | Drug: Phenoxybenzamine | Open-heart Surgery Cardiopulmonary Bypass |
University of Arkansas | February 2001 | Phase 2 |
NCT03176693 | Completed | Drug: Phenoxybenzamine Drug: Doxazosin |
Pheochromocytoma Paraganglioma |
University of California, Los Angeles |
May 5, 2017 | Phase 3 |
Phenoxybenzamine, over a broad dose range, provides significant neuroprotection from oxygen glucose deprivation in rat hippocampal slices cultures. Int J Mol Sci . 2014 Jan 20;15(1):1402-17. td> |
Phenoxybenzamine (PBZ), delivered up to 16 h post injury, provides significant neuroprotection from oxygen glucose deprivation in rat hippocampal slice cultures. Int J Mol Sci . 2014 Jan 20;15(1):1402-17. td> |
Phenoxybenzamine, delivered 8 h after a severe traumatic brain injury (TBI) significantly reduced neurological impairment. Int J Mol Sci . 2014 Jan 20;15(1):1402-17. td> |